title: Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
abstract: A 13-year old girl suffering from beta-thalassaemia major received bone marrow transplantation (BMT) from her HLA identical bother. After initial engraftment, she developed mixed chimerism. Secondary graft rejection occurred at 10 months after BMT and resulted in marrow aplasia. A second transplant with the same bone marrow donor was performed. The patient was conditioned with antithymocyte globulin 90 mg/kg followed by peripheral blood stem cell infusion. There was prompt engraftment and patient reverted to complete chimerism. There were no severe treatment-related complications or acute or chronic graft versus host disease after second transplant. The patient remained transfusion independent at 26 months after second transplant.
authors.affiliation: Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong. ckli@cuhk.edu.hk
authors.forename: Chi Kong
authors.initials: CK
authors.lastname: Li
authors.forename: Matthew Ming Kong
authors.initials: MM
authors.lastname: Shing
authors.forename: Ki Wai
authors.initials: KW
authors.lastname: Chik
authors.forename: Vincent
authors.initials: V
authors.lastname: Lee
authors.forename: Kam Sze
authors.initials: KS
authors.lastname: Tsang
authors.forename: Patrick Man Pan
authors.initials: PM
authors.lastname: Yuen
mesh_terms: D000293:Adolescent; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D005260:Female; D006084:Graft Rejection; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D019233:Retreatment; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D017086:beta-Thalassemia / Q000473:pathology / Q000628:therapy*
chemical_list: D000961:Antilymphocyte Serum